Abstract
A series of studies carried out at the University of Pittsburgh point strongly to the lifetime nature of recurrent unipolar disorder and to the need for a long-term perspective in the development of treatment strategies. In our initial investigation (Frank et al., 1990), remitted recurrent unipolar patients were randomly assigned to full dose ≈220 mg imipramine) maintenance pharmacotherapy, monthly maintenance psychotherapy, the combination or placebo for a period of three years. Full dose medication was highly effective (p < 0.0001) in preventing new episodes, with maintenance psychotherapy showing a modest protective effect (p = 0.05). In a second investigation (Kupfer et assignment. A third investigation (Frank et al., 1993), focused on those patients in the original study who had experienced a recurrence in the absence of active pharmacotherapy. Following successful treatment of their recurrence and a 20-week continuation treatment phase, these subjects were randomly assigned to either full or half-dose pharmacotherapy for a three-year period. Full-dose imipramine was associated with fewer recurrences and longer survival time than the half-dose strategy (p < 0.07).
Taken together, these studies of recurrent unipolar patients present a picture of a disorder requiring long-term (if not life-long) prophylaxis in a manner similar al., 1992), subjects who survived the initial three-year trial in one of the two active medication conditions, were randomly assigned to an additional two years of full-dose pharmacotherapy or placebo. Once again, active medication was significantly superior to placebo (p < 0.006) in protecting against new episodes, this time in a group of patients who had all previously sustained a remission of almost 3.5 years prior to random to that apparently required in manic-depressive illness. What remains to be elucidated is: (1) whether more frequent maintenance psychotherapy can provide adequate protection against recurrence and (2) whether there are subgroups of recurrent unipolar patients who can ultimately discontinue treatment without adverse consequences.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frank, E. Should Depression Be Considered a Lifetime Disorder: Evidence from the Pittsburgh Studies of Maintenance Therapy. Neuropsychopharmacol 11, 259–260 (1994). https://doi.org/10.1038/sj.npp.1380118
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.npp.1380118